Healthy Volunteer Receives NIAID Zika Virus Investigational DNA Vaccine (IMAGE)
Caption
A healthy volunteer receives the NIAID Zika virus investigational DNA vaccine as part of an early-stage trial to test the vaccine's safety and immunogenicity. This is the first administration of this vaccine in a human.
Credit
NIAID
Usage Restrictions
None
License
Licensed content